AIToday
Log inSign up free
Back to articlesLarge Language Models
Large Language ModelsAI in Healthcare

OpenAI launches GPT-Rosalind, an advanced AI model designed to accelerate drug discovery and genomics research.

OpenAI BlogApr 16, 20261 min read
OpenAI launches GPT-Rosalind, an advanced AI model designed to accelerate drug discovery and genomics research.

Summaries like this, in your inbox every morning.

Sign up free →

3 Key Points

  1. GPT-Rosalind is a frontier reasoning model built specifically for life sciences applications

  2. The model is designed to accelerate drug discovery, genomics analysis, and protein reasoning workflows

  3. The tool aims to enhance scientific research processes through advanced AI capabilities

Sign up to read moreRead Original Article

Discussion

No comments yet. Be the first to share your thoughts!

Log in to join the discussion

Related Articles

AI agent conducts first fully autonomous ransomware attack

THE DECODER3h ago

Open-source tool cuts Claude, GPT token costs 59–70% by hiding text in images

THE DECODER1d ago

Alibaba bans Claude Code, citing security risk

TechCrunch AI1d ago

Mistral AI eyes €1.7 billion Series C, claims path to $1 billion（約1600億円） ARR

TechCrunch AI2d ago

Anthropic dev: Claude Fable 5 quality now limited by user's blind spots, not model

THE DECODER2d ago

Qpilot: AI agent automates manual browser testing without code

Hacker News2d ago

Stay ahead with AI news

Get curated AI news from 200+ sources delivered daily to your inbox. Free to use.

Get Started Free

Free · takes 30 seconds · unsubscribe anytime

1 minute a day. The AI essentials.

200+ sources · Email / LINE / Slack

Get it free →